-

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IOVANCE BIOTHERAPEUTICS, INC. (IOVA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On May 8, 2025, Iovance released its first quarter 2025 financial results, revealing a quarterly total product revenue of $49.3 million, a significant decline from the prior quarter’s $73.7 million. The Company also announced its full fiscal year 2025 total product revenue guidance had been slashed from $450 million - $475 million to $250 million - $300 million, a reduction of over 40% at the midpoint. The Company stated it was “revising full-year 2025 revenue guidance to reflect recent launch dynamics” of the Company’s T cell immunotherapy, Amtagvi® (lifileucel). Amtagvi was commercially launched in the U.S. in the first half of 2024.

On this news, Iovance’s stock price fell as much as 52% during intraday trading on May 9, 2025, thereby injuring investors.

Contact Us to Participate or Learn More:

If you purchased Iovance securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, Pennsylvania 19020
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com
Visit our website at: www.howardsmithlaw.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Industry:

Law Offices of Howard G. Smith

NASDAQ:IOVA
Release Versions
English

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Deadline Alert: D-Wave Quantum, Inc. Stockholders Face December 15, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 15, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 26, 2026 through August 25, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Fessler v. D-Wave Quant...

Securities Fraud Class Action Lawsuit Pending Against UP Fintech Holding Limited: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

BENSALEM, Pa.--(BUSINESS WIRE)--UP Fintech Holding Limited ("UP Fintech" or the "Company") (NASDAQ: TIGR) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from April 22, 2024 through June 2, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Liao v. Up Fintech Holdings Limited et al, which was filed on October 26, 2026 in the U.S. District Court District of New Jersey (...

Securities Fraud Class Action Lawsuit Pending Against D-Wave Quantum, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

BENSALEM, Pa.--(BUSINESS WIRE)--D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 26, 2026 through August 25, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Fessler v. D-Wave Quantum, Inc. et al., which was filed on October 15, 2026 in the U.S. District Court California Northern District (C...
Back to Newsroom